Comparison between ARC Insulation IPO and Asston Pharmaceuticals IPO.
ARC Insulation IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Asston Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.
| ARC Insulation IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | JSK Securities & Services Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ARC Insulation IPO is up to ₹39.13 Cr whereas the issue size of the Asston Pharmaceuticals IPO is up to ₹26.17 Cr. The final issue price of ARC Insulation IPO is ₹125.00 per share and of Asston Pharmaceuticals IPO is ₹123.00 per share.
| ARC Insulation IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹119.00 per share | ₹115.00 per share |
| Issue Price (Upper) | ₹125.00 per share | ₹123.00 per share |
| Issue Price (Final) | ₹125.00 per share | ₹123.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1000 shares |
| Fresh Issue Size | 28,80,000 shares | 21,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹36.00 Cr | up to ₹26.17 Cr |
| OFS Issue Size | 2,50,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹3.13 Cr | up to ₹0.00 Cr |
| Issue Size Total | 31,30,000 shares | 21,28,000 shares |
| Issue Size Total (Amount) | up to ₹39.13 Cr | up to ₹26.17 Cr |
ARC Insulation IPO opens on Aug 21, 2025, while Asston Pharmaceuticals IPO opens on Jul 09, 2025. The closing date of ARC Insulation IPO and Asston Pharmaceuticals IPO is Aug 25, 2025, and Jul 11, 2025, respectively.
| ARC Insulation IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Aug 20, 2025 | Jul 08, 2025 |
| Issue Open | Aug 21, 2025 | Jul 09, 2025 |
| Issue Close | Aug 25, 2025 | Jul 11, 2025 |
| Basis Of Allotment (Tentative) | Aug 26, 2025 | Jul 14, 2025 |
| Initiation of Refunds (Tentative) | Aug 28, 2025 | Jul 15, 2025 |
| Credit of Share (Tentative) | Aug 28, 2025 | Jul 15, 2025 |
| Listing date (Tentative) | Aug 29, 2025 | Jul 16, 2025 |
| Anchor Lockin End date 1 | Sep 25, 2025 | Aug 13, 2025 |
| Anchor Lockin End date 2 | Nov 24, 2025 | Oct 12, 2025 |
ARC Insulation IPO P/E ratio is 10.58, as compared to Asston Pharmaceuticals IPO P/E ratio of 17.83.
| ARC Insulation IPO | Asston Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | EBITDA | Asston Pharmaceuticals Limited Financial Information (Restated)Asston Pharmaceuticals Limited's revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 94.48 | 68.76 | |||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.11 | 50.66 | |||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 10.58 | 17.83 | |||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹128.72 Cr. | ₹104.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||
| ROE | 45.47% | 50.56% | |||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 49.84% | 51.25% | |||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 0.68 | |||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.81 | ₹6.90 | |||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 45.47% | 40.36% | |||||||||||||||||||||||||||||||||||||||||||||
In the ARC Insulation IPO Retail Individual Investors (RII) are offered 10,96,000 shares while in Asston Pharmaceuticals IPO retail investors are offered 10,96,000 shares. Qualified Institutional Buyers (QIB) are offered 6,26,000 shares in ARC Insulation IPO and 4,25,000 shares in Asston Pharmaceuticals IPO.
| ARC Insulation IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | 9,37,000 shares | 6,35,000 shares |
| Market Maker Reserveration | 1,65,000 shares | 1,13,000 shares |
| QIB | 6,26,000 shares | 4,25,000 shares |
| NII | 4,71,000 shares | 3,22,000 shares |
| RII | 10,96,000 shares | 7,46,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 31,30,000 shares | 21,28,000 shares |
ARC Insulation IPO subscribed 18.71x in total, whereas Asston Pharmaceuticals IPO subscribed 186.55x.
| ARC Insulation IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 15.12x | 85.76x |
| NII (times) | 26.84x | 353.14x |
| Big NII (times) | 29.26x | 424.47x |
| Small NII (times) | 22.01x | 210.85x |
| RII (times) | 17.27x | 172.06x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.71x | 186.55x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
